News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,455 signal articles · 146 in last 24h · 154,143 total before filter · latest 1h ago

146last 24h

877last 7d

147● bullish (7d)

96● bearish (7d)

214publishers

All Macro211 Earnings108 M&A126 Regulatory21 Product21 Analyst17

✕ clear all filtersticker: UNHsentiment: bearishSentiment:bullish neutral bearish show all (incl. clickbait)

Simply Wall St.72d agobearish

UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands

The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...

UNH

MT Newswires72d agobearish

Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev

(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se

CI CVS UNH

MT Newswires72d agobearish

Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev

(Update with the Justice Department's response to a request for comment in the third paragraph.)

CI CVS UNH

Healthcare Dive85d agobearish

Court dismisses PBMs’ lawsuit against FTC following insulin settlements

Express Scripts, Caremark and Optum Rx sued the FTC after the agency accused them of driving up the cost of insulin. But the countersuit is being put to bed now that the PBMs are settling with regulators.

CVS UNH